Association between the C3435T single-nucleotide polymorphism of multidrug resistance 1 gene and risk of gastric cancer

Molecular Medicine Reports

Volumn 6, Issue 2, 2012, Pages 395-398

  Oliveira, Juliana ^a   Felipe, Aledson V ^a   Chang, Paula Y J ^a   Pimenta, Celia A M ^a   Silva, Tiago D ^a   Massud, João ^a   Forones, Nora M ^a  

^a Federal University of Sao Paolo   (Brazil)

Author keywords

Gastric cancer; Multidrug resistance 1; Polymorphism

Indexed keywords

DNA; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CONTROLLED STUDY; DNA EXTRACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HELICOBACTER PYLORI; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

AGED; CASE-CONTROL STUDIES; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 84863493810     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.926     Document Type: Article

References (26)

1. Instituto Nacional de Câncer - INCA. Brasília: Ministério da Saúde. Estimativa 2012: Incidência de Câncer no Brasil. Available at: http://www.inca.gov.br/estimativa/2012/ estimative 20122111.pdf
2. Matysiak-Budnika T and Mégraudb F: H. pylori infection and gastric cancer. Eur J Cancer 42: 708-716, 2006.
3. Wen S and Moss SF: H. pylori virulence factors in gastric carcinogenesis. Cancer Lett 282: 1-8, 2009.
4. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M and Boyle P: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592, 2007. (Pubitemid 46359643)
5. Correa P and Houghton J: Carcinogenesis of Helicobacter pylori. Gastroenterology 133: 659-672, 2007. (Pubitemid 47187360)
6. Shin CM, Kim N, Lee HS, Lee DH, Kim JS, Jung HC and Song IS: Intrafamilial aggregation of gastric cancer: a comprehensive approach including environmental factors, Helicobacter pylori virulence, and genetic susceptibility. Eur J Gastroenterol Hepatol 23: 411-417, 2011.
7. Ueda K, Cornwell MM, Gottesman MM, Pastan I, Roninson IB, Ling V and Riordan JR: The MDR1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 141: 956-962, 1986. (Pubitemid 17006141)
8. van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P and van Meer G: MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87: 507-517, 1996. (Pubitemid 26374324)
9. Dey S: Single nucleotide polymorphisms in human P-glycoprotein: its impact on drug delivery and disposition. Expert Opin Drug Deliv 3: 23-35, 2006.
10. Thörn M, Finnström N, Lundgren S, Rane A and Lööf L: Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Br J Clin Pharmacol 60: 54-60, 2005.
11. Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM and Pastan I: Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. Cancer Res 46: 5941-9546, 1986.
12. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I and Willingham MC: Cellular localisation of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738, 1987.
13. Jäeger W: Classical resistance mechanisms. Int J Clin Pharmacol Ther 47: 46-48, 2009.
14. Ho GT, Moodie FM and Satsangi J: Multidrug resistance 1 gene (Pglycoprotein170): an important determinant in gastrointestinal disease? Gut 52: 759-766, 2003. (Pubitemid 36528884)
15. Paule B, Castagne V, Picard V, Saffroy R, Adam R, Guettier C, Farinotti R and Bonhomme-Faivre L: MDR1 polymorphism role in patients treated with cetuximab and irinotecan in refractory colorectal cancer. Med Oncol 27: 1066-1072, 2010.
16. Sugimoto M, Furuta T, Shirai N, et al: MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese. Life Sci 83: 301-304, 2008.
17. Tahara T, Arisawa T, Shibata T, Hirata I and Nakano H: Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. J Gastroenterol Hepatol 22: 1678-1682, 2007. (Pubitemid 47383331)
18. Taheri M, Mahjoubi F and Omranipour R: Effect of MDR1 polymorphism on multidrug resistance expression in breast cancer patients. Genet Mol Res 9: 34-40, 2010.
19. Turgut S, Turgut G and Atalay EO: Genotype and allele frequency of human multidrug resistance (MDR1) gene C3435T polymorphism in Denizli province of Turkey. Mol Biol Rep 33: 295-300, 2006. (Pubitemid 44760400)
20. Rao DN, C Anuradha, Vishnupriya S, Sailaja K, Surekha D, Raghunadharao D and Rajappa S: Association of an MDR1 gene (C3435T) polymorphism with acute leukemia in India. Asian Pac J Cancer Prev 11: 1063-1066, 2010.
21. Jamroziak K, Balcerczak E, Cebula B, et al: Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia. Pharmacol Rep 57: 882-888, 2005.
22. Schwab M, Schaeffeler E, Marx C, et al: Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 124: 26-33, 2003. (Pubitemid 36055335)
23. Sabahi Z, Salek R, Heravi RE, et al: Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. Indian J Cancer 47: 317-321, 2010.
24. Balram C, Sharma A, Sivathasen C and Lee EJ: Frequency of C3435T single nucleotide MDR1 genetic polymorphism in an Asia population: phenotypic-genotypic correlates. Br J Clin Pharmacol 56: 78-83, 2003. (Pubitemid 36886491)
25. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV and Gottesman MM: A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528, 2007. (Pubitemid 46175758)
26. Mizuarai S, Aozasa N and Kotani H: Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2: Int J Cancer 109: 238-246, 2004. (Pubitemid 38240926)